Key Growth Drivers

1. Further expansion of Cephalosporin Oral and Sterile product basket
2. Entry into Regulated Markets for supply to MNC of Cephalosporin Sterile – 12 DMF filed in USA /EU/Canada
3. Venturing into Non-Beta lactam products with lesser competition and higher Gross Margins
4. Building strength in Custom synthesis & Contract Manufacturing for innovator MNCs (CRAMS)
5. Building World class infrastructure for getting EU / US FDA approval
6. Investment in Research and Development for replenishing future Product pipeline – 40 Products under various stages of development
7. Constant Expansion of Overseas markets – already exporting to over 40 semi-regulated countries
8. Increasing Domestic market penetration
9. Focus on cost competitiveness in processes
10. Focus on Total Quality – in inputs, Finished Goods, processes, Equipment and manpowers .